Autoimmune pancytopenia following chronic immune thrombocytopenia: Case report and literature review

Blood Cells Mol Dis. 2020 Sep:84:102455. doi: 10.1016/j.bcmd.2020.102455. Epub 2020 May 29.

Authors

Angelo Gardellini¹, Francesca Guidotti², Michelle Zancanella¹, Vittoria Saccà¹, Maddalena Feltri³, Luciana Ambrosiani³, Mauro Turrini¹

Affiliations

¹ Division of Hematology, Department of Medicine, Valduce Hospital, Como, Italy.
² Division of Hematology, Department of Medicine, Valduce Hospital, Como, Italy. Electronic address: francesca_guidotti@yahoo.it.
³ Department of Pathology, Valduce Hospital, Como, Italy.

PMID: 32502698
DOI: 10.1016/j.bcmd.2020.102455

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Aged
Benzoates / therapeutic use
Bone Marrow / drug effects
Bone Marrow / pathology
Chronic Disease
Cyclosporine / therapeutic use
Humans
Hydrazines / therapeutic use
Immunologic Factors / therapeutic use
Immunosuppressive Agents / therapeutic use
Male
Pancytopenia / drug therapy
Pancytopenia / etiology*
Pancytopenia / pathology
Purpura, Thrombocytopenic, Idiopathic / complications*
Purpura, Thrombocytopenic, Idiopathic / drug therapy
Purpura, Thrombocytopenic, Idiopathic / pathology
Pyrazoles / therapeutic use
Receptors, Thrombopoietin / agonists
Rituximab / therapeutic use

Substances

Benzoates
Hydrazines
Immunologic Factors
Immunosuppressive Agents
Pyrazoles
Receptors, Thrombopoietin
Rituximab
Cyclosporine
eltrombopag